Beaulieu-lès-Loches (FR)
{name}
{subtitle}
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy
city
~26 mi. (Lillette, France, +55 more cities)
facility
Centre Hospitalier Régional Universitaire de Lille (Adults and Pediatrics)
condition
Post-Transplant Lymphoproliferative Disorder
drug
tabelecleucel
drug type
cellular therapy, +1 more type
A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
city
~32 mi. (Tours, France, +197 more cities)
facility
CHRU Tours - Hopital Bretonneau /ID# 216186
biomarker
BCR-ABL1 Fusion, +47 more biomarkers
condition
Acute Myeloid Leukemia
drug
azacitidine, +1 more drug
drug type
chemotherapy
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~32 mi. (Tours, France, +142 more cities)
facility
CHU Bretonneau
biomarker
del(11)(q10), +27 more biomarkers
condition
Myelofibrosis
drug
imetelstat, +1 more drug
drug type
targeted therapy
A Study to Assess the Efficacy and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
city
~51 mi. (La Chaussée-Saint-Victor, France, +84 more cities)
facility
Site FR33016
biomarker
CLDN18 Expression
condition
Pancreatic Adenocarcinoma
drug
gemcitabine, +2 more drugs
drug type
chemotherapy, +1 more type